Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Reliq Health Technologies Inc. specializes in developing software solutions for the healthcare sector, focusing on remote patient monitoring and chronic care management. Its unique competitive advantage lies in its proprietary platform, which integrates seamlessly with existing healthcare systems and is designed to improve patient outcomes while reducing costs for healthcare providers.
Reliq generates revenue primarily through a subscription model for its software, which allows healthcare providers to monitor patients remotely. This model provides recurring revenue and high gross margins of 62%. The company benefits from strong pricing power due to the increasing demand for telehealth solutions, particularly in the wake of the COVID-19 pandemic.
Adoption rates of telehealth solutions among healthcare providers
Regulatory changes that promote remote patient monitoring
Partnerships with major healthcare systems
Growth in chronic disease prevalence driving demand for monitoring solutions
Technological disruption from emerging telehealth competitors
Regulatory changes that could impact reimbursement models for remote monitoring
Intense competition from established healthcare IT companies
Emerging startups offering similar or superior technology solutions
Negative operating cash flow could limit growth opportunities
High reliance on continued investment to sustain growth
moderate - Reliq's business is somewhat insulated from economic cycles as demand for healthcare services tends to remain stable; however, budget constraints in healthcare can impact spending on technology.
Interest rates affect Reliq primarily through the cost of capital for potential acquisitions or expansions. Higher rates could dampen growth if financing becomes more expensive.
minimal - Reliq has a low debt-to-equity ratio of 0.05, indicating limited reliance on external financing.
growth - investors are likely attracted to Reliq due to its high revenue growth rate of 485% YoY and potential for scalability in the telehealth market.
high - Reliq has experienced significant stock price volatility, reflected in its 1-year return of -58.7%.
